Skip to content

Clinical trials

Osteosarcoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Country / region: China Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20131
20151
20161
20174
20186
20196
20205
20214
20222
20238
202411
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status24
Completed14
Recruiting11
Not yet recruiting3
Active, not recruiting2
Suspended2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital23
Ruijin Hospital5
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Sun Yat-sen University4
Hansoh BioMedical R&D Company2
Shanghai Yunying Medical Technology2
Base Therapeutics (Shanghai) Co., Ltd.1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Changye Zou1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma58
Sarcoma13
Sarcoma, Ewing7
Bone Neoplasms4
Drug-Related Side Effects and Adverse Reactions3
Recurrence3
Chondrosarcoma2
Disease Progression2
Adenocarcinoma of Lung1
Carcinoma, Hepatocellular1

Trials

Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.